The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
NCT00397540 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145
Last updated 2019-03-18
Summary
The purpose of this study is to evaluate the effect of serum hepatitis B virus (HBV) DNA level on intrahepatic recurrence in locally treatable hepatocellular carcinomas (HCCs) related with HBV.
Conditions
- Carcinoma, Hepatocellular
- Chronic Hepatitis B
Interventions
- PROCEDURE
-
PEIT
Percutaneous Ethanol Injection Therapy
- PROCEDURE
-
RFTA
Radiofrequency Thermal Ablation
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Won Kim, Professor · Seoul National University Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication
NCT01894269 ·Status: UNKNOWN ·Phase: PHASE4
-
TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma
NCT07253220 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma
NCT06365034 ·Status: RECRUITING
-
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
NCT06086002 ·Status: COMPLETED ·Phase: NA
-
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation
NCT04237740 ·Status: UNKNOWN ·Phase: PHASE3
-
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy
NCT05197504 ·Status: COMPLETED
-
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
NCT01643824 ·Status: COMPLETED ·Phase: NA
-
Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study
NCT04680598 ·Status: UNKNOWN
-
Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load
NCT02308319 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
NCT04646928 ·Status: UNKNOWN
-
Impact of Hepatectomy on HCC Recurrence
NCT06390228 ·Status: COMPLETED
-
TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.
NCT06669377 ·Status: RECRUITING
-
Lenvatinib Therapy in HCC Patients After LDLT
NCT05572528 ·Status: RECRUITING
-
Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma
NCT02425605 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC
NCT02563158 ·Status: UNKNOWN ·Phase: NA
-
Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients
NCT02523053 ·Status: UNKNOWN ·Phase: NA
-
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
NCT01872988 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
NCT00768157 ·Status: UNKNOWN ·Phase: PHASE4
-
Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC
NCT02650271 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC
NCT06519721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation
NCT02719782 ·Status: UNKNOWN ·Phase: PHASE1
-
A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection
NCT03914352 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea
NCT06620510 ·Status: COMPLETED
-
Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment
NCT05677724 ·Status: UNKNOWN